BASINGSTOKE, United Kingdom, Nov. 17, 2025 (GLOBE NEWSWIRE) — A new study by global tech strategists Juniper Research has revealed that the modern card issuing platforms market will increase from $1.8 billion in 2025 to $4.2 billion by 2030; driven by rising interest from traditional banks trying to keep pace with innovative fintech offerings. Juniper […]
Modern Card Issuing Platforms Market to Surpass $4.2 Billion by 2030, as Juniper Research Reveals Global Leaders Driving Fintech Innovation GlobeNewswire November 17, 2025 BASINGSTOKE, United Kingdom, Nov. 17, 2025 (GLOBE NEWSWIRE) — A new study by global tech strategists Juniper Research has revealed that the modern card issuing platforms market will increase from $1.8
Pulsar Helium to Host Virtual Site Visit and Q&A with CEO Thomas Abraham-James and Helium-3 Advisor Dr Peter Barry THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH
Maxion Tech Co., ltd. is thrilled to announce that Pre-RegistrationforRagnarokOnline Landverse America that is underofficial license fromGRAVITY Co., Ltd. (NasdaqGM: GRVY)is now open! https://mma.prnewswire.com/media/2824258/image_5018407_4096547.jpg Launching on December 11, 2025, this title brings the legendaryRagnarok Onlineuniverse into theWeb3 era, combining nostalgic MMORPG gameplay with blockchain-based item ownership and a player-driven economy. Starting fromNovember 13, 2025, players
XTransfer, World's Leading B2B Cross-Border Trade Payment Platform and Siam Commercial Bank (SCB), Thailand's first indigenous bank, announced the signing of a memorandum of understanding (MoU) at Singapore FinTech Festival 2025. The collaboration will focus on delivering efficient, secure, and cost-effective foreign exchange (FX) services in Thailand for enterprises engaging in international trade. https://mma.prnewswire.com/media/2824391/SCB_XT_MOU.jpg Under
(AUST:MSB.AX),(NASDAQ:MESO), NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company's transition to a fully integrated commercial organization it has appointed James M. O'Brien as its US-based Chief Financial Officer (CFO). Jim has extensive experience in
James M. O'Brien Appointed Chief Financial Officer at Mesoblast GlobeNewswire November 17, 2025 NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company's transition to a fully integrated commercial organization it has appointed James M. O'Brien
Sheridan, WY, Nov. 17, 2025 (GLOBE NEWSWIRE) — Ascend Vitality announced today that it has expanded its fully licensed telehealth operations across all 50 states, reinforcing its position as a provider of physician-directed access to compounded peptide formulations and weight-related medical care delivered through remote consultations. The expansion marks a formal step in the company's
Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies GlobeNewswire November 17, 2025 Sheridan, WY, Nov. 17, 2025 (GLOBE NEWSWIRE) — Ascend Vitality announced today that it has expanded its fully licensed telehealth operations across all 50 states, reinforcing its position as a provider of physician-directed access to compounded peptide
(Brussels:ONWD),(Euronext Amsterdam:ONWD),(OTC US:ONWRY),(Other OTC:ONWRY), THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX(R) System both in clinics and homes ARC-EX is the first and only FDA-cleared technology demonstrated to improve hand strength and sensation in people